Short answer
Healthpeak Properties (DOC) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $216M (up 45.4% year over year) with net income of $53M.
Q2 2026 key financials · XBRL
- Revenue
- $216M
- +45.4% YoY · +8.0% QoQ
- Net income
- $53M
- +66.8% YoY · −72.7% QoQ
- EPS (diluted)
- $0.08
- +60.0% YoY · −71.4% QoQ
Source: XBRL data from the Healthpeak Properties (DOC) Q2 2026 10-Q on SEC EDGAR. USD.
Healthpeak Properties Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Segment Adjusted NOI: outpatient medical $198.005M, lab $142.614M, senior housing $45.851M
- Best-performing segment outpatient medical with $206.587M NOI
- Janus Living offerings generated $1.685B gross proceeds, less $93M underwriting fees
- Capital deployment included $100M share repurchases and $399M seller-financing principal repayment
- Headwinds: elevated interest rates, higher construction costs, tariffs, capital constraints, and healthcare policy uncertainty
Risk Factors
- No risk-factors section provided; changes from the most recent 10-K cannot be assessed
- Share repurchase authorization: 2024 program expired July 2026
- New $500 million repurchase program approved July 30, 2026
- Liquidity allocation: $100 million spent repurchasing 5.95 million shares at $16.81 per share
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Healthpeak Properties quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.